Literature DB >> 6619530

Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3'-triiodothyroacetic acid (TRIAC).

P Beck-Peccoz, G Piscitelli, M G Cattaneo, G Faglia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6619530     DOI： 10.1007/BF03350611

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  20 in total

1.  Estimation of thyroid function by timing the arterial sounds.

Authors:  D Rodbard; T Fujita; S Rodbard
Journal:  JAMA       Date:  1967-09-11       Impact factor: 56.272

2.  Secretion of alpha subunit of glycoprotein hormones by pituitary adenomas.

Authors:  I A Kourides; B D Weintraub; S W Rosen; E C Ridgway; B Kliman; F Maloof
Journal:  J Clin Endocrinol Metab       Date:  1976-07       Impact factor: 5.958

3.  Measurement of free thyroid hormones in serum by column adsorption chromatography and radioimmunoassay.

Authors:  P B Romelli; F Pennisi; L Vancheri
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

4.  A case of the syndrome of inappropriate secretion of TSH.

Authors:  T Sato; K Saida; Y Suzuki; I Takata; K Ishiguro
Journal:  Endocrinol Jpn       Date:  1979-10

5.  Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".

Authors:  M C Gershengorn; B D Weintraub
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease.

Authors:  E Macchia; G F Fenzi; F Monzani; F Lippi; P Vitti; L Grasso; L Bartalena; L Baschieri; A Pinchera
Journal:  Clin Endocrinol (Oxf)       Date:  1981-08       Impact factor: 3.478

7.  Augmentation of thyrotropin responses to thyrotropin-releasing hormone following small decreases in serum thyroid hormone concentrations.

Authors:  M Saberi; R D Utiger
Journal:  J Clin Endocrinol Metab       Date:  1975-03       Impact factor: 5.958

8.  Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones.

Authors:  A Burger; D Dinichert; P Nicod; M Jenny; T Lemarchand-Béraud; M B Vallotton
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

9.  Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine.

Authors:  A Rösler; Y Litvin; C Hage; J Gross; E Cerasi
Journal:  J Clin Endocrinol Metab       Date:  1982-01       Impact factor: 5.958

10.  The diminished cardiac performance in severe thyrotoxicosis. Parabolic correlation of LVET/PEP to the circulating levels of thyroid hormones.

Authors:  H Suzuki; K Kasai; S I Shimoda
Journal:  J Endocrinol Invest       Date:  1981 Jul-Sep       Impact factor: 4.256
View more
  13 in total

1.  Clinical hyperthyroidism due to non-neoplastic inappropriate thyrotrophin secretion.

Authors:  A W Chan; I A MacFarlane; C van Heyningen; P M Foy
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

Review 2.  Pituitary resistance to thyroid hormones: pathophysiology and therapeutic options.

Authors:  Satoru Suzuki; Satoshi Shigematsu; Hidefumi Inaba; Masahiro Takei; Teiji Takeda; Mitsuhisa Komatsu
Journal:  Endocrine       Date:  2011-09-29       Impact factor: 3.633

3.  Dissociated thyromimetic effects of 3, 5, 3'-triiodothyroacetic acid (TRIAC) at the pituitary and peripheral tissue levels.

Authors:  P Beck-Peccoz; A Sartorio; C De Medici; G Grugni; F Morabito; G Faglia
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

4.  Hyperthyroidism due to familial pituitary resistance to thyroid hormone: successful control with 3, 5, 3' triiodothyroacetic associated to propranolol.

Authors:  M Aguilar Diosdado; L Escobar-Jimenez; M L Fernandez Soto; A Garcia Curiel; F Escobar-Jimenez
Journal:  J Endocrinol Invest       Date:  1991-09       Impact factor: 4.256

5.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

6.  Approach to the patient with resistance to thyroid hormone and pregnancy.

Authors:  Roy E Weiss; Alexandra Dumitrescu; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2010-07       Impact factor: 5.958

7.  Anti-iodothyronine autoantibodies in a girl with hyperthyroidism due to pituitary resistance to thyroid hormones.

Authors:  A Crinò; P Borrelli; R Salvatori; D Cortelazzi; R Roncoroni; P Beck-Peccoz
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

8.  Pituitary resistance to thyroid hormone action with preserved circadian rhythm of thyrotropin in a postmenopausal woman.

Authors:  N Custro; V Scafidi; A Notarbartolo
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

Review 9.  The syndromes of reduced sensitivity to thyroid hormone.

Authors:  Alexandra M Dumitrescu; Samuel Refetoff
Journal:  Biochim Biophys Acta       Date:  2012-08-16

10.  Abnormal daily periodicity of serum thyrotropin (TSH) and evidence for defective TSH suppression in a case of non-neoplastic syndrome of inappropriate TSH secretion.

Authors:  S Benvenga; G A Sobbrio; F Vermiglio; L Li Calzi; S Cannavò; F Consolo; F Trimarchi
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.